Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Genzyme Corporation

MA, United States

CMS manufacturer 100000000297

Open in the dashboard

General payments

$296,076,397

884,853 payments

Research payments

$222,386,761

21,311 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Genzyme Corporation reported paying $296,076,397 in general payments and $222,386,761 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $61,224,697 204,032
2025 Research $50,319,486 3,974
2024 General $57,615,505 182,526
2024 Research $39,386,217 3,046
2023 General $46,855,161 162,739
2023 Research $24,116,245 3,302
2022 General $35,413,874 127,882
2022 Research $44,988,645 3,748
2021 General $35,517,553 82,120
2021 Research $26,705,190 2,695
2020 General $23,602,179 40,609
2020 Research $15,343,383 2,109
2019 General $35,847,428 84,945
2019 Research $21,527,594 2,437

Breakdown

Top recipients General payments · program year 2025
  1. Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $17,101,881 12 payments
  2. Charles Sawyers Hematology & Oncology · New York, NY $1,271,522 2 payments
  3. University Of Washington Med Ctr Teaching hospital · WA $497,427 19 payments
  4. Raj Chovatiya Dermatology · Chicago, IL $278,929 101 payments
  5. Guy Young Pediatric Hematology-Oncology · Bozeman, MT $256,560 95 payments
  6. Cedric Franklin Rutland Critical Care Medicine · Riverside, CA $211,728 69 payments
  7. Alexandra Golant Dermatology · New York, NY $193,047 76 payments
  8. Mario Castro Pulmonary Disease · Kansas City, KS $185,389 61 payments
  9. Leonard Bacharier Pediatric Allergy/Immunology · Nashville, TN $183,281 83 payments
  10. Maeve Oconnor Allergy & Immunology · Charlotte, NC $172,494 103 payments
Top research recipients Research payments · program year 2025
  1. Duke University Gsrb1 4th Fl $2,153,781 59 payments
  2. Massachusetts General Hospital Cancer Center $1,643,741 2 payments
  3. Ut Md Anderson Cancer Center Teaching hospital · TX $1,411,946 11 payments
  4. Medical Coll Of Wisconsin $1,293,075 8 payments
  5. Mckesson Medical Surgical $1,043,902 1 payment
  6. Mount Sinai School Of Medicine Psychiatry $1,040,387 27 payments
  7. Yale University Keck Biotechnology Laboratory $938,702 3 payments
  8. Emory University Hospital Teaching hospital · GA $808,036 20 payments
  9. Froedtert Mem. Lutheran Hospt. Teaching hospital · WI $785,535 5 payments
  10. Alabama Neurology Associates Pc $755,190 35 payments
Products the payments named General payments · program year 2025
  1. Dupixent Immunology $28,431,388 79% · 38,175 recipients
  2. Kevzara Rheumatology $1,464,199 4% · 2,007 recipients
  3. Sarclisa Oncology $1,175,551 3% · 4,053 recipients
  4. Altuviiio Hematology $924,548 3% · 419 recipients
  5. Fabrazyme Genetic Disease $848,072 2% · 1,663 recipients

The top 5 of 24 products; each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

The top 25 products, free in the app

Specialties paid General payments · program year 2025
  1. Dermatology $7,513,537 18% · 5,373 practitioners
  2. Pulmonary Disease Internal Medicine $4,427,634 11% · 3,167 practitioners
  3. Allergy & Immunology $3,308,212 8% · 1,643 practitioners
  4. Hematology & Oncology Internal Medicine $3,204,488 8% · 2,322 practitioners
  5. Gastroenterology Internal Medicine $2,785,376 7% · 4,296 practitioners

The top 5 of 225 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Michigan $18,358,886 30% · 1,634 recipients
  2. New York $5,216,990 9% · 3,504 recipients
  3. California $5,170,616 8% · 4,732 recipients
  4. Texas $3,509,754 6% · 4,507 recipients
  5. Florida $3,239,767 5% · 5,215 recipients

The top 5 of 53 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $103,466,548 33,243 payments
  2. Royalty or License $94,951,021 40 payments
  3. Consulting Fee $42,496,552 10,584 payments
  4. Food and Beverage $24,882,784 799,022 payments
  5. Travel and Lodging $15,259,805 39,063 payments
  6. Grant $10,505,454 748 payments
  7. Space rental or facility fees (teaching hospital only) $2,105,736 1,011 payments
  8. Acquisitions $1,266,522 1 payment
  9. Charitable Contribution $1,032,678 41 payments
  10. Compensation for serving as faculty or as a speaker for a medical education program $67,646 30 payments
884,853 general · 21,311 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record